menu
    • menu

    Company profile for Invectys

    Suanfarma, at the Core of a Better Life.

    Virtual Booth

    Contact Supplier

    Jai Radhe Sales is your partner for all your sourcing needs.

    Virtual Booth

    Contact Supplier

    Centrient is a leading manufacturer of Beta-Lactam Antibiotics and a provider of next-generation Statins and Antifungals.

    Virtual Booth

    Contact Supplier

    Moehs Group, a reference company in the production of pharmaceutical active ingredients.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Founded in 2010 and based in Paris, Invectys is a biopharmaceutical company focused on the development of innovative immunotherapy approaches to treat cancer. Invectys exploits a novel approach to mobilizing and restoring the anti-tumor capacity of the immune system of cancer patients. This allows virtually all cancers to be targeted. Invectys focuses its efforts on the universal tumor antigen telomerase that is critical to...
    Founded in 2010 and based in Paris, Invectys is a biopharmaceutical company focused on the development of innovative immunotherapy approaches to treat cancer. Invectys exploits a novel approach to mobilizing and restoring the anti-tumor capacity of the immune system of cancer patients. This allows virtually all cancers to be targeted. Invectys focuses its efforts on the universal tumor antigen telomerase that is critical to uncontrolled cell growth.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    InvectysFrance Flag
    Country
    Country
    France
    Address
    Address
    Paris Biopark 12 rue Jean Antoine de Baïf F – 75013 PARIS
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.invectys.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    FDA Grants Fast Track designation to IVS-3001, a CAR-T Cell Therapy
    FDA Grants Fast Track designation to IVS-3001, a CAR-T Cell Therapy

    31 Jul 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2023/07/31/2714663/0/en/FDA-Grants-Fast-Track-designation-to-IVS-3001-a-CAR-T-Cell-Therapy-in-the-Treatment-of-Renal-Cell-Carcinoma.html

    GLOBENEWSWIRE
    31 Jul 2023
    Share Share
    Invectys Announces Initiation of Phase 1/2a Clinical Trial in Solid Tumors
    Invectys Announces Initiation of Phase 1/2a Clinical Trial in Solid Tumors

    13 Jul 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2023/07/13/2704421/0/en/Invectys-Announces-Initiation-of-Phase-1-2a-Clinical-Trial-in-Solid-Tumors-and-Change-in-Leadership.html

    GLOBENEWSWIRE
    13 Jul 2023
    Share Share
    INVECTYS, INC. TO PARTICIPATE IN THE 41st JP MORGAN HEALTHCARE CONFERENCE
    INVECTYS, INC. TO PARTICIPATE IN THE 41st JP MORGAN HEALTHCARE CONFERENCE

    05 Jan 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com//news-release/2023/01/05/2583615/0/en/INVECTYS-INC-TO-PARTICIPATE-IN-THE-41st-JP-MORGAN-HEALTHCARE-CONFERENCE-ON-JANUARY-9-12-2023.html

    GLOBENEWSWIRE
    05 Jan 2023
    Share Share
    Updated Invectys and CTMC announce FDA clearance of IND application
    Updated Invectys and CTMC announce FDA clearance of IND application

    20 Dec 2022

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2022/12/20/2577098/0/en/Updated-Invectys-and-CTMC-announce-FDA-clearance-of-IND-application-for-anti-HLA-G-CAR-T-cell-therapy.html

    GLOBENEWSWIRE
    20 Dec 2022
    Share Share
    Invectys and CTMC announce FDA clearance of IND application for anti-HLA-G CAR-T
    Invectys and CTMC announce FDA clearance of IND application for anti-HLA-G CAR-T

    19 Dec 2022

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2022/12/19/2576489/0/en/Invectys-and-CTMC-announce-FDA-clearance-of-IND-application-for-anti-HLA-G-CAR-T-cell-therapy.html

    GLOBENEWSWIRE
    19 Dec 2022
    Share Share
    Invectys, MD Anderson And CTMC Announce Collaboration For Car T Cell Therapy
    Invectys, MD Anderson And CTMC Announce Collaboration For Car T Cell Therapy

    16 Jun 2022

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2022/06/16/2464034/0/en/INVECTYS-MD-ANDERSON-AND-CTMC-ANNOUNCE-STRATEGIC-COLLABORATION-FOR-CAR-T-CELL-THERAPY-DEVELOPMENT.html

    GLOBENEWSWIRE
    16 Jun 2022
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search